NEW YORK (GenomeWeb News) - Thermo Fisher Scientific today reported a 12 percent drop in first-quarter revenues and a 35 percent fall in net profit as it lowered its guidance for full-year 2009 by $400 million.

"The tough economy had a significant impact on our results for the first quarter, particularly in our instrumentation and equipment businesses," Marijn Dekkers, president and CEO of the company, said in a statement. "Our customers are clearly delaying their capital purchases in the current environment."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.

The New York Times editorial board weighs in on scientific research misconduct.

The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.

The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.